2Pilefi SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells:an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology, 2002, 41 : 1 - 29. 被引量:1
3Vos JA, Abbondanzo SL, Barekman CLet al. Histiocytic sarcoma:a study of five cases including the histiocyte marker CD163. Mod Pathol, 2005, 18:693 - 704. 被引量:1
4Pfreundschuh M, Trumper L, Kloess M, et al. Two-weekly or 3- weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood, 2004, 104:626 - 633. 被引量:1
5Abidi MH, Tore I, Ibrahim RB, et al. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. Am J Hematol, 2007, 82:932 - 933. 被引量:1
6Hornick JL, Jaffe ES, Fletcher CD, et al. Extranodal histiocytic sarcoma clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol, 2004, 28:1133 - 1144. 被引量:1
7Piled SA, Giogan TM, Harris NL, et al.Tumours of histiocytes and accessory dendritic ceils: an immunohistochemical approach to classification from the Intemational Lymphoma Study Group based on 61 cases [J]. Histopathology, 2002,41 ( 1 ) : 1-29. 被引量:1
8Homick JL,Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 eases of a rare epithelioid malignancy [J]. Am J Sury Pathol,2004,28(9) : 1133-1144. 被引量:1
9Sun W,Nordberg ML, Fowler MR. Histiocytie sarcoma involving the central nervous system: clinical, immunohistochemieal, and molecular genetic studies of a ease with review of the literature[J]. Am J Surg Pathol, 2003,27 (2) : 258-265. 被引量:1
10Kobayashi S,Kimura F,Hama Y,et al. Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocypenia and complex imaging features[J]. Int J Hematol, 2008,87 ( 1 ) : 83-87. 被引量:1